AbbVie to present at Cowen and Co. Health Care Conference

American Pharmacy News Reports | Feb 20, 2017
For those unable to log on at the time of the conference, an archived copy of the recording will be available.
For those unable to log on at the time of the conference, an archived copy of the recording will be available. | File photo
AbbVie, a global biopharmaceutical company focused on research, will take part in the upcoming Cowen and Co. 37th Annual Health Care Conference. 
Executive Vice President and Chief Financial Officer William Chase will present March 8 at 8:20 a.m. CST.
The conference will be available for those who cannot attend via a live audio webcast on AbbVie's Investor Relations' site. The link to the webcast will be posted at investors.abbvie.com. For those unable to log on at the time of the conference, an archived copy of the recording will be available.
AbbVie was created in 2013 and the company has worked hard to develop treatments and therapies for diseases around the world.
More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry News NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry News TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry News MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020